基本信息
浏览量:1
职业迁徙
个人简介
Regulation of post-ischemic inflammation in brain injury and repair
Inflammation is a central aspect in the pathophysiology of stroke, the third leading-cause of death and serious disability in US and western countries. Although numerous experimental studies based on immune modulatory therapies have shown promise, attempts to use such strategies in the clinic have not been successful. One of the main reasons is our poor understanding of the postischemic inflammation process. The inflammatory response is initiated during the early phase of ischemia by activation of intravascular immune cells and circulating humoral factors (e.g. complement system and coagulation cascade) as well as the vascular endothelium creating an environment that leads to blood brain barrier breakdown. Inflammatory molecules generated in the vasculature can consequently reach perivascular cells (i.e. perivascular macrophages, mast cells and glia limitans) resulting in an amplification of the inflammatory signals. This sets the stage for activation of microglia, the main brain-resident immune cell, and the infiltration of various blood born leukocytes, that play a crucial role in the development of the ischemic injury but may also contribute to the resolution of inflammation and postischemic tissue repair. Applying anti-inflammatory therapies that indiscriminately target both branches of the immune response might therefore not be successful.
One focus of our laboratory is to investigate how peripheral immune cells help to limit inflammatory tissue damage and contribute to the repair process.
Our laboratory also aims at understanding endogenous neuroprotection. The brain is equipped with a remarkable capacity to mount self-protective programs that are tuned to limit the deleterious effects of ischemia, commonly referred to as endogenous neuroprotection. These protective programs can be invoked by preconditioning (PC) stimuli that is the application of sublethal stressors, resulting in cerebral ischemic tolerance (CIT). In this research project we test the hypothesis that immune cells outside the brain play an essential role in establishing CIT and we investigate the molecular mechanisms that trigger this response.
Inflammation is a central aspect in the pathophysiology of stroke, the third leading-cause of death and serious disability in US and western countries. Although numerous experimental studies based on immune modulatory therapies have shown promise, attempts to use such strategies in the clinic have not been successful. One of the main reasons is our poor understanding of the postischemic inflammation process. The inflammatory response is initiated during the early phase of ischemia by activation of intravascular immune cells and circulating humoral factors (e.g. complement system and coagulation cascade) as well as the vascular endothelium creating an environment that leads to blood brain barrier breakdown. Inflammatory molecules generated in the vasculature can consequently reach perivascular cells (i.e. perivascular macrophages, mast cells and glia limitans) resulting in an amplification of the inflammatory signals. This sets the stage for activation of microglia, the main brain-resident immune cell, and the infiltration of various blood born leukocytes, that play a crucial role in the development of the ischemic injury but may also contribute to the resolution of inflammation and postischemic tissue repair. Applying anti-inflammatory therapies that indiscriminately target both branches of the immune response might therefore not be successful.
One focus of our laboratory is to investigate how peripheral immune cells help to limit inflammatory tissue damage and contribute to the repair process.
Our laboratory also aims at understanding endogenous neuroprotection. The brain is equipped with a remarkable capacity to mount self-protective programs that are tuned to limit the deleterious effects of ischemia, commonly referred to as endogenous neuroprotection. These protective programs can be invoked by preconditioning (PC) stimuli that is the application of sublethal stressors, resulting in cerebral ischemic tolerance (CIT). In this research project we test the hypothesis that immune cells outside the brain play an essential role in establishing CIT and we investigate the molecular mechanisms that trigger this response.
研究兴趣
论文共 173 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nature Immunologyno. 2 (2024): 357-370
Research squareno. 1 (2023): 1-20
引用1浏览0WOS引用
1
0
Luisa Rubinelli,Lidia Garcia-Bonilla,Linda Sasset,Anna Cantalupo, Benjamin Goya, James E Ip,Josef Anrather,Costantino Iadecola,Giuseppe Faraco,Annarita Di Lorenzo
Circulation researchno. 10 (2023): 880-882
STROKEno. 6 (2023): E251-E271
引用11浏览0WOS引用
11
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn